NCT02164279View on ClinicalTrials.gov

Validation of Biomarkers of Diabetic Nephropathy in Type I Diabetic Children

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

May 25, 2016

Study Completion Date

May 25, 2016

Conditions
Type 1 Diabetes Mellitus With Diabetic Nephropathy
Interventions
OTHER

Urinary sample collection

urinary sample collection will be done at the inclusion visit for the assessment of the microalbuminuria ( \< or \> than 100mg/L)

Trial Locations (2)

31059

Purpan Children Hospital, Toulouse

Rangueil Hospital, Toulouse

All Listed Sponsors
collaborator

Laboratory Inserm U858 Team 5 - RF-lab

UNKNOWN

lead

University Hospital, Toulouse

OTHER

NCT02164279 - Validation of Biomarkers of Diabetic Nephropathy in Type I Diabetic Children | Biotech Hunter | Biotech Hunter